The Immunoregulatory Role of the Signal Regulatory Protein Family and CD47 Signaling Pathway in Type 1 Diabetes

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2021 Oct 4

PMID 34603322

Citations 7

Authors

Robert C Sharp

Matthew E Brown

Melanie R Shapiro

Amanda L Posgai

Todd M Brusko

Affiliations

Soon will be listed here.

Abstract

Background: The pathogenesis of type 1 diabetes (T1D) involves complex genetic susceptibility that impacts pathways regulating host immunity and the target of autoimmune attack, insulin-producing pancreatic β-cells. Interactions between risk variants and environmental factors result in significant heterogeneity in clinical presentation among those who develop T1D. Although genetic risk is dominated by the human leukocyte antigen (HLA) class II and insulin () gene loci, nearly 150 additional risk variants are significantly associated with the disease, including polymorphisms in immune checkpoint molecules, such as .

Scope Of Review: In this review, we summarize the literature related to the T1D-associated risk variants in , which include a protein-coding variant (rs6043409, G>A; A263V) and an intronic polymorphism (rs2281808, C>T), and their potential impacts on the immunoregulatory signal regulatory protein (SIRP) family:CD47 signaling axis. We discuss how dysregulated expression or function of SIRPs and CD47 in antigen-presenting cells (APCs), T cells, natural killer (NK) cells, and pancreatic β-cells could potentially promote T1D development.

Major Conclusions: We propose a hypothesis, supported by emerging genetic and functional immune studies, which states a loss of proper SIRP:CD47 signaling may result in increased lymphocyte activation and cytotoxicity and enhanced β-cell destruction. Thus, we present several novel therapeutic strategies for modulation of SIRPs and CD47 to intervene in T1D.

Citing Articles

SIRPα engagement regulates ILC2 effector function and alleviates airway hyperreactivity via modulating energy metabolism.

Sakano Y, Sakano K, Hurrell B, Shafiei-Jahani P, Kazemi M, Li X Cell Mol Immunol. 2024; 21(10):1158-1174.

PMID: 39160226 PMC: 11442993. DOI: 10.1038/s41423-024-01208-z.

Single-cell RNA Sequencing Reveals Novel Cellular Factors for Response to Immunosuppressive Therapy in Aplastic Anemia.

Jang J, Kim H, Park S, Kim M, Min Y, Jeong H Hemasphere. 2023; 7(11):e977.

PMID: 37908861 PMC: 10615405. DOI: 10.1097/HS9.0000000000000977.

The pathogenic "symphony" in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas.

Atkinson M, Mirmira R Cell Metab. 2023; 35(9):1500-1518.

PMID: 37478842 PMC: 10529265. DOI: 10.1016/j.cmet.2023.06.018.

The TSP1-CD47-SIRPα interactome: an immune triangle for the checkpoint era.

Montero E, Isenberg J Cancer Immunol Immunother. 2023; 72(9):2879-2888.

PMID: 37217603 PMC: 10412679. DOI: 10.1007/s00262-023-03465-9.

Emerging phagocytosis checkpoints in cancer immunotherapy.

Liu Y, Wang Y, Yang Y, Weng L, Wu Q, Zhang J Signal Transduct Target Ther. 2023; 8(1):104.

PMID: 36882399 PMC: 9990587. DOI: 10.1038/s41392-023-01365-z.

References

Oldenborg P . CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease. ISRN Hematol. 2013; 2013:614619. PMC: 3564380. DOI: 10.1155/2013/614619. View

Hayes B, Tsai R, Dooling L, Kadu S, Lee J, Pantano D . Macrophages show higher levels of engulfment after disruption of interactions between CD47 and the checkpoint receptor SIRPα. J Cell Sci. 2020; 133(5). PMC: 7064788. DOI: 10.1242/jcs.237800. View

Torn C, Hadley D, Lee H, Hagopian W, Lernmark A, Simell O . Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study. Diabetes. 2014; 64(5):1818-29. PMC: 4407865. DOI: 10.2337/db14-1497. View

Quang Van V, Raymond M, Baba N, Rubio M, Wakahara K, Susin S . CD47(high) expression on CD4 effectors identifies functional long-lived memory T cell progenitors. J Immunol. 2012; 188(9):4249-55. DOI: 10.4049/jimmunol.1102702. View

Tseng D, Volkmer J, Willingham S, Contreras-Trujillo H, Fathman J, Fernhoff N . Anti-CD47 antibody-mediated phagocytosis of cancer by macrophages primes an effective antitumor T-cell response. Proc Natl Acad Sci U S A. 2013; 110(27):11103-8. PMC: 3703977. DOI: 10.1073/pnas.1305569110. View

Li Z, He L, Wilson K, Roberts D . Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation. J Immunol. 2001; 166(4):2427-36. DOI: 10.4049/jimmunol.166.4.2427. View

Reddy M, Wang H, Liu S, Bode B, Reed J, Steed R . Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun. 2011; 12(3):208-12. PMC: 3952552. DOI: 10.1038/gene.2010.70. View

Lamy L, Ticchioni M, Rouquette-Jazdanian A, Samson M, Deckert M, Greenberg A . CD47 and the 19 kDa interacting protein-3 (BNIP3) in T cell apoptosis. J Biol Chem. 2003; 278(26):23915-21. DOI: 10.1074/jbc.M301869200. View

Lv Z, Bian Z, Shi L, Niu S, Ha B, Tremblay A . Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages. J Immunol. 2015; 195(2):661-71. PMC: 4490976. DOI: 10.4049/jimmunol.1401719. View

10.

Kawabata Y, Ikegami H . Genetics of fulminant type 1 diabetes. Diabetol Int. 2020; 11(4):315-322. PMC: 7538480. DOI: 10.1007/s13340-020-00468-0. View

11.

Anna A, Monika G . Splicing mutations in human genetic disorders: examples, detection, and confirmation. J Appl Genet. 2018; 59(3):253-268. PMC: 6060985. DOI: 10.1007/s13353-018-0444-7. View

12.

Westra H, Martinez-Bonet M, Onengut-Gumuscu S, Lee A, Luo Y, Teslovich N . Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes. Nat Genet. 2018; 50(10):1366-1374. PMC: 6364548. DOI: 10.1038/s41588-018-0216-7. View

13.

Dugas V, Beauchamp C, Chabot-Roy G, Hillhouse E, Lesage S . Implication of the CD47 pathway in autoimmune diabetes. J Autoimmun. 2010; 35(1):23-32. DOI: 10.1016/j.jaut.2010.01.002. View

14.

Barrett J, Clayton D, Concannon P, Akolkar B, Cooper J, Erlich H . Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6):703-7. PMC: 2889014. DOI: 10.1038/ng.381. View

15.

Kataoka S, Satoh J, Fujiya H, Toyota T, Suzuki R, Itoh K . Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes. 1983; 32(3):247-53. DOI: 10.2337/diab.32.3.247. View

16.

Miller T, Kaur S, Ivins-OKeefe K, Roberts D . Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation. Matrix Biol. 2013; 32(6):316-24. PMC: 3706541. DOI: 10.1016/j.matbio.2013.02.009. View

17.

Pugliese A . Autoreactive T cells in type 1 diabetes. J Clin Invest. 2017; 127(8):2881-2891. PMC: 5531393. DOI: 10.1172/JCI94549. View

18.

Legrand N, Huntington N, Nagasawa M, Bakker A, Schotte R, Strick-Marchand H . Functional CD47/signal regulatory protein alpha (SIRP(alpha)) interaction is required for optimal human T- and natural killer- (NK) cell homeostasis in vivo. Proc Natl Acad Sci U S A. 2011; 108(32):13224-9. PMC: 3156191. DOI: 10.1073/pnas.1101398108. View

19.

Cham L, Adomati T, Li F, Ali M, Lang K . CD47 as a Potential Target to Therapy for Infectious Diseases. Antibodies (Basel). 2020; 9(3). PMC: 7551396. DOI: 10.3390/antib9030044. View

20.

Storling J, Pociot F . Type 1 Diabetes Candidate Genes Linked to Pancreatic Islet Cell Inflammation and Beta-Cell Apoptosis. Genes (Basel). 2017; 8(2). PMC: 5333061. DOI: 10.3390/genes8020072. View